Search research articles
Contact Us
Filters
Showing results (161-170 of 226) with videos related to
Page
of 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2007
Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1
Anthony W Tolcher, Monica Mita, Neal J Meropol, et al.
Pancreas
|
March 12, 2016
Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma
Efrat Dotan, R Katherine Alpaugh, Karen Ruth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 12, 2012
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer
Andre Konski, Tianyu Li, Michael Christensen, et al.
European Urology
|
August 1, 2019
Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer
Emily Feld, Joanna Harton, Neal J Meropol, et al.
Urology
|
January 3, 2016
Racial Disparities in Partial Nephrectomy Persist Across Hospital Types: Results From a Population-based Cohort
Jonathan E Kiechle, Robert Abouassaly, Cary P Gross, et al.
The Journal of Urology
|
June 23, 2015
Variation in Surgical Margin Status by Surgical Approach among Patients Undergoing Partial Nephrectomy for Small Renal Masses
William Tabayoyong, Robert Abouassaly, Jonathan E Kiechle, et al.
Urology
|
June 19, 2016
Disparities in Treatment of Patients With High-risk Prostate Cancer: Results From a Population-based Cohort
Elyn H Wang, James B Yu, Robert Abouassally, et al.
Clinical Colorectal Cancer
|
February 12, 2014
A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers
Crystal S Denlinger, Neal J Meropol, Tianyu Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 3, 2014
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer
Andre Konski, Joshua E Meyer, Michael Joiner, et al.
Cancer Causes & Control : CCC
|
May 27, 2019
Development and validation of a model to predict outcomes of colon cancer surveillance
Johnie Rose, Laura Homa, Chung Yin Kong, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 226) with videos related to
Sort By:
Page
of 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2007
Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1
Anthony W Tolcher, Monica Mita, Neal J Meropol, et al.
Pancreas
|
March 12, 2016
Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma
Efrat Dotan, R Katherine Alpaugh, Karen Ruth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 12, 2012
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer
Andre Konski, Tianyu Li, Michael Christensen, et al.
European Urology
|
August 1, 2019
Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer
Emily Feld, Joanna Harton, Neal J Meropol, et al.
Urology
|
January 3, 2016
Racial Disparities in Partial Nephrectomy Persist Across Hospital Types: Results From a Population-based Cohort
Jonathan E Kiechle, Robert Abouassaly, Cary P Gross, et al.
The Journal of Urology
|
June 23, 2015
Variation in Surgical Margin Status by Surgical Approach among Patients Undergoing Partial Nephrectomy for Small Renal Masses
William Tabayoyong, Robert Abouassaly, Jonathan E Kiechle, et al.
Urology
|
June 19, 2016
Disparities in Treatment of Patients With High-risk Prostate Cancer: Results From a Population-based Cohort
Elyn H Wang, James B Yu, Robert Abouassally, et al.
Clinical Colorectal Cancer
|
February 12, 2014
A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers
Crystal S Denlinger, Neal J Meropol, Tianyu Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 3, 2014
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer
Andre Konski, Joshua E Meyer, Michael Joiner, et al.
Cancer Causes & Control : CCC
|
May 27, 2019
Development and validation of a model to predict outcomes of colon cancer surveillance
Johnie Rose, Laura Homa, Chung Yin Kong, et al.
Page
of 23